Clinical Trial Update: A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial evaluating the safety and efficacy of BZL101 for metastatic breast cancer has completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• BZL101

Snippet

Sponsor: Bionovo | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-03-16